fda approval of tirzepatide for weight loss Grants a New Indication Obesity Management FDA approves new version of

Tune in to hear Suzy Badaracco, president of Culinary Tides, and Sherry Frey, vice president, Total Wellness, NielsenIQ, in a conversation guided by Michael Costa, managing editor of Food Business News , as they highlight the effect GLP-1 medications are having on consumer packaged goods companies

Unveiling tirzepatide's therapeutic spectrum: A dual GIP/GLP-1 agonist targeting metabolic, neurological, and cardiovascular health

A pilot clinical study by Sasaninia et al

It affects a natural process in the body that controls blood flow, helping more blood reach injured areas

Semaglutide also mimics a hormone that targets areas of the brain to reduce appetite

These programs can help you get semaglutide at a reduced cost